Versant Venture Management, LLC Crinetics Pharmaceuticals, Inc. Transaction History

Versant Venture Management, LLC

  • $38.2 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$16.49 - $27.64 $6.77 Million - $11.3 Million
-410,360 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$19.35 - $28.41 $7.94 Million - $11.7 Million
-410,360 Reduced 50.0%
410,360 $11.7 Million
Q2 2021

Aug 12, 2021
SELL
$15.9 - $21.15 $19.2 Million - $25.6 Million
-1,209,896 Reduced 59.58%
820,720 $15.5 Million
Q2 2020

Jul 20, 2020
BUY
$13.04 - $23.23 $26.5 Million - $47.2 Million
2,030,616 New
2,030,616 $35.6 Billion

Others Institutions Holding CRNX

# of Institutions
241
Shares Held
79.5M
Call Options Held
23.3K
Put Options Held
44.3K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.9B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Versant Venture Management, LLC Portfolio

Follow Versant Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email